Psychological and pharmacological interventions for depression in patients with coronary artery disease

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Baumeister, Harald ^a   Hutter, Nico ^a   Bengel, Jürgen ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MONOAMINE OXIDASE INHIBITOR; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CARDIOVASCULAR RISK; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEPRESSION; HEART RATE VARIABILITY; HUMAN; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REMISSION; REVIEW;

EID: 77950158557     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008012     Document Type: Review

References (37)

1. Alpert 2000 Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Journal of the American College of Cardiology 2000;36:959-69.
2. Antman 2004 Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al.ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004;44:e82-e292.
3. APA 1994 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 4th Edition. Washington, DC: American Psychiatric Association, 1994.
4. Barth 2004 Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosomatic Medicine 2004;66:802-13.
5. Baumeister 2005 Baumeister H, Balke K, Härter M. Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients. Journal of Clinical Epidemiology 2005;58: 1090-100.
6. Baumeister 2007 Baumeister H, Härter M. Mental disorders in patients with obesity in comparison with healthy probands. International Journal of Obesity 2007;31:1155-64.
7. Berkman 2003 Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, et al.Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD). Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003;289: 3106-16.
8. Budde 2005 Budde T, Breithardt G. [Koronare Herzkrankheit]. In: Greten H editor(s). Innere Medizin: Verstehen-Lernen-Anwenden. Stuttgart: Thieme, 2005:34-54.
9. Davidson 2006 Davidson KW, Kupfer DJ, Bigger JT, Califf RM, Carney RM, Coyne JC, et al.Assessment and treatment of depression in patients with cardiovascular disease: National heart, lung, and blood institute working group report. Annals of Behavioral Medicine 2006; 32:121-6.
10. Davison 2003 Davison GC, Neale JM. Abnormal Psychology. New York: John Wiley & Sons, 2003.
11. Dickens 2008 Dickens C, McGowan L, Percival C, Tomenson B, Cotter L, Heagerty A, et al.New onset depression following myocardial infarction predicts cardiac mortality. Psychosomatic Medicine 2008; 70:450-5.
12. Fox 2006 Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, et al.Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. European Heart Journal 2006;27:1341-81.
13. Frasure-Smith 2000 Frasure-Smith N, Lesperance F, Gravel G, Masson A, Juneau M, Talajic M, et al.Depression and health-care costs during the first year following myocardial infarction. Journal of Psychosomatic Research 2000;48:471-8.
14. Frasure-Smith 2003 Frasure-Smith N, Lesperance F. Depression and other psychological risks following myocardial infarction. Archives of General Psychiatry 2003;60:627-36.
15. Herrmann-Lingen 2006 Herrmann-Lingen C, Buss U. Anxiety and depression in patients with coronary heart disease. In: Jordan J, Bardé B, Zeiher AM editor(s). Contributions toward evidence-based psychocardiology: a systematic review of the literature. Washington, DC: American Psychological Association, 2006:125-57.
16. Higgins 2008 Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008.
17. Härter 2007a Härter M, Baumeister H. [Ätiologie psychischer Störungen bei chronischen körperlichen Erkrankungen]. In: Härter M, Baumeister H, Bengel J editor(s). Psychische Störungen bei körperlichen Erkrankungen. Heidelberg: Springer, 2007:1-13.
18. Härter 2007b Härter M, Baumeister H, Reuter K, Jacobi F, Höfler M, Bengel J, et al.Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychotherapy and Psychosomatics 2007;6:354-60.
19. Joynt 2003 Joynt KE, Whellan DJ, O'Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biological Psychiatry 2003;54:248-61.
20. Lesperance 2007 Lesperance F, Frasure-Smith N, Koszycki D, Laliberte MA, van Zyl LT, Baker B, et al.Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007;297:367-79.
21. Lichtman 2008 Lichtman JH, Bigger JT, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lesperance F, et al.Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 2008;118:1768-775.
22. Moncrieff 2004 Moncrieff J, Wessely S, Hardy R. Active placebos versus antidepressants for depression. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/ 14651858.CD003012.pub2]
23. Mottram 2006 Mottram PG, Wilson K, Strobl JJ. Antidepressants for depressed elderly. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD003491.pub2]
24. Musselman 1998 Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Archives of General Psychiatry 1998;55:580-92.
25. Ormel 2007 Ormel J, Von Korff M, Burger H, Scott K, Demyttenaere K, Huang YQ, et al.Mental disorders among persons with heart disease - results from World Mental Health surveys. General Hospital Psychiatry 2007;29:325-34.
26. Pollock 2000 Pollock BG, Laghrissi-Thode F, Wagner WR. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. Journal of Clinical Psychopharmacology 2000;20:137-40.
27. Rees 2004 Rees K, Bennett P, West R, Davey Smith G, Ebrahim S. Psychological interventions for coronary heart disease. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD002902.pub2]
28. Rudisch 2003 Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biological Psychiatry 2003;54:227-40.
29. Sadock 2005 Sadock BJ, Sadock VA (eds). Kaplan & Sadock's comprehensive textbook of psychiatry. 8th Edition. Philadelphia, Pa. ; London: Lippincott Williams & Wilkins, 2005.
30. Serebruany 2003 Serebruany VL, Glassman AH, Malinin AI, Nemeroff CB, Musselman DL, van Zyl LT, et al.Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline Anti Depressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation 2003;108:939-44.
31. Silva de Lima 2005 Silva de Lima M, Moncrieff J, Soares B. Drugs versus placebo for dysthymia. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD001130]
32. Skala 2006 Skala JA, Freedland KE, Carney RM. Coronary heart disease and depression: A review of recent mechanistic research. Canadian Journal of Psychiatry 2006;51:738-45.
33. Spijkerman 2005 Spijkerman T, de Jonge P, van den Brink RHS, Jansen JHC, May JF, Crijns HJGM, et al.Depression following myocardial infarction: first-ever versus ongoing and recurrent episodes. General Hospital Psychiatry 2005;27:411-7.
34. Thombs 2006 Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, Patel U, et al.Prevalence of depression in survivors of acute myocardial infarction. Journal of General Internal Medicine 2006;21:30-8.
35. WHO 1992 World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders. Clinical description and diagnostic guidelines. 10th Edition. Geneva: World Health Organization, 1992.
36. Yeragani 2002 Yeragani VK, Pesce V, Jayaraman A, Roose S. Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures. Biological Psychiatry 2002;52:418-29.
37. Ziegelstein 2000 Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Archives of Internal Medicine 2000;160: 1818-23.